Graham Capital Management’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $89.4K | Buy |
|
|||||
|
2025
Q1 | $49.9K | Buy |
|
|||||
|
2024
Q4 | $41.9K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $34.7K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $37.8K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $853K | Buy |
|
|||||
|
2022
Q2 | $153K | Sell |
|
|||||
|
2022
Q1 | $547K | Buy |
|
|||||
|
2021
Q4 | $298K | Buy |
|